Peter C. Ligthart

1.3k total citations
42 papers, 913 citations indexed

About

Peter C. Ligthart is a scholar working on Hematology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter C. Ligthart has authored 42 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 24 papers in Physiology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter C. Ligthart's work include Blood groups and transfusion (34 papers), Erythrocyte Function and Pathophysiology (23 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Peter C. Ligthart is often cited by papers focused on Blood groups and transfusion (34 papers), Erythrocyte Function and Pathophysiology (23 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Peter C. Ligthart collaborates with scholars based in Netherlands, United States and China. Peter C. Ligthart's co-authors include C. Ellen van der Schoot, Masja de Haas, D.J. van Rhenen, B. H. W. Faas, Gestur Vidarsson, M.A.M. Overbeeke, Erik A.M. Beckers, Manfred Wuhrer, Petra A. Maaskant‐van Wijk and Leszek Berger and has published in prestigious journals such as Blood, The Journal of Immunology and Annals of Neurology.

In The Last Decade

Peter C. Ligthart

41 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Ligthart Netherlands 18 661 465 205 205 193 42 913
Andrew G. Hadley United Kingdom 20 573 0.9× 290 0.6× 270 1.3× 300 1.5× 362 1.9× 42 962
Kenichi Ogasawara Japan 17 869 1.3× 580 1.2× 140 0.7× 60 0.3× 24 0.1× 61 1.0k
Gregory R. Halverson United States 14 341 0.5× 382 0.8× 199 1.0× 79 0.4× 38 0.2× 32 626
Britt Thuresson Sweden 12 276 0.4× 197 0.4× 102 0.5× 82 0.4× 20 0.1× 23 412
M.C. Magli Netherlands 4 178 0.3× 38 0.1× 122 0.6× 93 0.5× 42 0.2× 7 417
J M Houlihan United Kingdom 6 105 0.2× 93 0.2× 62 0.3× 370 1.8× 55 0.3× 7 579
Milcho Mincheff United States 16 113 0.2× 49 0.1× 273 1.3× 322 1.6× 25 0.1× 30 678
O Asai Japan 11 281 0.4× 69 0.1× 117 0.6× 436 2.1× 42 0.2× 17 726
Paul Guglielmi France 14 116 0.2× 42 0.1× 278 1.4× 415 2.0× 109 0.6× 23 758
Carlo Calissano United States 10 123 0.2× 20 0.0× 205 1.0× 375 1.8× 64 0.3× 15 956

Countries citing papers authored by Peter C. Ligthart

Since Specialization
Citations

This map shows the geographic impact of Peter C. Ligthart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Ligthart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Ligthart more than expected).

Fields of papers citing papers by Peter C. Ligthart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Ligthart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Ligthart. The network helps show where Peter C. Ligthart may publish in the future.

Co-authorship network of co-authors of Peter C. Ligthart

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Ligthart. A scholar is included among the top collaborators of Peter C. Ligthart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Ligthart. Peter C. Ligthart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bondt, Albert, Peter C. Ligthart, E. J. T. Verweij, et al.. (2025). Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies. Transfusion.
2.
Record, Christopher J., Antoinette O’Connor, Wouter van Rheenen, et al.. (2024). Recessive Variants in PIGG Cause a Motor Neuropathy with Variable Conduction Block, Childhood Tremor, and Febrile Seizures: Expanding the Phenotype. Annals of Neurology. 97(2). 388–396. 1 indexed citations
3.
Lane, William J., Sunitha Vege, Christine Lomas‐Francis, et al.. (2021). PIGG defines the Emm blood group system. Scientific Reports. 11(1). 18545–18545. 6 indexed citations
4.
Brinkhaus, Maximilian, Arthur E. H. Bentlage, Steven W. de Taeye, et al.. (2020). Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function. The Journal of Immunology. 205(12). 3456–3467. 11 indexed citations
5.
Taeye, Steven W. de, Erik L. de Graaf, Gillian Dekkers, et al.. (2019). Functional Attributes of Antibodies, Effector Cells, and Target Cells Affecting NK Cell–Mediated Antibody-Dependent Cellular Cytotoxicity. The Journal of Immunology. 203(12). 3126–3135. 49 indexed citations
6.
Baas, Inge O., Peter C. Ligthart, Claudia C. Folman, et al.. (2019). Complement C3 inhibition by compstatin Cp40 prevents intra- and extravascular hemolysis of red blood cells. Haematologica. 105(2). e57–e60. 17 indexed citations
7.
Klei, Thomas R., Francesca Aglialoro, Erik Mul, et al.. (2019). Differential interaction between DARC and SDF-1 on erythrocytes and their precursors. Scientific Reports. 9(1). 16245–16245. 7 indexed citations
8.
Klei, Thomas R., Djuna Z. de Back, Paul J.J.H. Verkuijlen, et al.. (2018). Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging. Blood Advances. 2(1). 14–24. 22 indexed citations
9.
Sonneveld, Myrthe E., Masja de Haas, Carolien A. M. Koeleman, et al.. (2017). Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation. Scientific Reports. 7(1). 8187–8187. 24 indexed citations
10.
Sonneveld, Myrthe E., Joke M. Koelewijn, Masja de Haas, et al.. (2016). Antigen specificity determines anti‐red blood cell IgG‐Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. British Journal of Haematology. 176(4). 651–660. 45 indexed citations
11.
Veldhuisen, Barbera, Peter C. Ligthart, Gestur Vidarsson, et al.. (2011). Molecular analysis of the York antigen of the Knops blood group system. Transfusion. 51(7). 1389–1396. 7 indexed citations
12.
Dohmen, Serge E., et al.. (2006). The restricted use of IGHV3 superspecies genes in anti‐Rh is not limited to hyperimmunized anti‐D donors. Transfusion. 46(12). 2162–2168. 3 indexed citations
13.
Beuling, Esther A., et al.. (2001). Partial expression of RHc on the RHD polypeptide. Transfusion. 41(9). 1136–1142. 14 indexed citations
14.
Faas, B. H. W., Erik A.M. Beckers, Peter C. Ligthart, et al.. (1997). Molecular background of VS and weak C expression in blacks. Transfusion. 37(1). 38–44. 141 indexed citations
15.
Faas, B. H. W., et al.. (1997). Involvement of Gly96 in the formation of the Rh26 epitope. Transfusion. 37(11-12). 1123–1130. 22 indexed citations
18.
Wijk, Petra A. Maaskant‐van, B. H. W. Faas, Peter C. Ligthart, et al.. (1996). Rh DNA analysis. Transfusion Clinique et Biologique. 3(6). 507–510. 4 indexed citations
19.
Rhenen, D.J. van, et al.. (1996). Reactions of anti-D monoclonal antibodies with rhesus D variant cells. Transfusion Clinique et Biologique. 3(6). 397–399. 2 indexed citations
20.
Beckers, Erik A.M., B. H. W. Faas, Peter C. Ligthart, et al.. (1996). Characterization of the hybrid RHD gene leading to the partial D category IIIc phenotype. Transfusion. 36(6). 567–574. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026